Kimberly-Clark to buy maker of Tylenol
Digest more
2don MSN
Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal
Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.
The lawsuit accuses pharmaceutical companies of “deceptively marketing” Tylenol as a safe option for pregnant mothers.
Health and Human Services Secretary Robert F. Kennedy Jr. further added to the Trump administration’s problematic claims about Tylenol and autism on Oct. 9, alleging during a Cabinet meeting that circumcision-related studies provide evidence that the drug causes the condition when given to children.
Recent headlines about acetaminophen use during pregnancy have left many expectant families feeling anxious, but experts say the link between the painkiller and autism is unproven
"The safety profile for Tylenol is impressive," Dr. Karam Radwan, Director of the UChicago Medicine Neurodevelopmental Clinic, tells PEOPLE, adding, "there's very few things that have a safety profile like that" President Donald Trump and Health and Human ...
When I was pregnant with my son, a friend invited me to a “pregnancy party” — you know, one of those meet-ups where women compare swollen ankles, sip sparkling water, and complain about their husbands. I thought it’d be a safe space.
18hon MSN
KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama
The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism. It’s been a tough few weeks for the consumer health company Kenvue,